版本:
中国

BRIEF-Sen. Grassley says HHS estimates taxpayers may have overpaid for Mylan's Epipen by as much as $1.27 bln from 2006-2016

May 31 Senator Chuck Grassley:

* Sen. Grassley says estimate from Department of Health & Human Services taxpayers may have overpaid for Mylan's Epipen by as much as $1.27 billion from 2006-2016

* Sen. Grassley says "it looks like Mylan overcharged the taxpayers for years with the knowledge Epipen was misclassified" Source text (bit.ly/2seTqJn) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐